154 related articles for article (PubMed ID: 23368102)
21. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase.
Zeng F; Quan L; Yang G; Qi T; Zhang L; Li S; Li H; Zhu L; Xu X
Molecules; 2019 Jul; 24(15):. PubMed ID: 31370178
[TBL] [Abstract][Full Text] [Related]
22. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues.
de Siqueira LRP; de Moraes Gomes PAT; de Lima Ferreira LP; de Melo Rêgo MJB; Leite ACL
Eur J Med Chem; 2019 May; 170():237-260. PubMed ID: 30904782
[TBL] [Abstract][Full Text] [Related]
23. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
[TBL] [Abstract][Full Text] [Related]
24. SYNTHESIS, ANTIMICROBIAL, ANTICANCER EVALUATION AND QSAR STUDIES OF THIAZOLIDIN-4-ONE DERIVATIVES.
Deep A; Kumar P; Narasimhan B; Lim SM; Ramasamy K; Mishra RK; Mani V
Acta Pol Pharm; 2016; 73(1):93-106. PubMed ID: 27008804
[TBL] [Abstract][Full Text] [Related]
25. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents.
Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G
J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, antimicrobial, anticancer evaluation of 2-(aryl)-4- thiazolidinone derivatives and their QSAR studies.
Deep A; Kumar P; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Majeed AB
Curr Top Med Chem; 2015; 15(11):990-1002. PubMed ID: 25786509
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
[TBL] [Abstract][Full Text] [Related]
28. Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction.
Dezi C; Carotti A; Magnani M; Baroni M; Padova A; Cruciani G; Macchiarulo A; Pellicciari R
J Chem Inf Model; 2010 Aug; 50(8):1451-65. PubMed ID: 20726601
[TBL] [Abstract][Full Text] [Related]
29. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
[TBL] [Abstract][Full Text] [Related]
30. Integrative and personalized QSAR analysis in cancer by kernelized Bayesian matrix factorization.
Ammad-ud-din M; Georgii E; Gönen M; Laitinen T; Kallioniemi O; Wennerberg K; Poso A; Kaski S
J Chem Inf Model; 2014 Aug; 54(8):2347-59. PubMed ID: 25046554
[TBL] [Abstract][Full Text] [Related]
31. Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization.
Zhao L; Wang Y; Cao D; Chen T; Wang Q; Li Y; Xu Y; Zhang N; Wang X; Chen D; Chen L; Chen YL; Xia G; Shi Z; Liu YC; Lin Y; Miao Z; Shen J; Xiong B
J Med Chem; 2015 Feb; 58(3):1281-97. PubMed ID: 25559428
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
[TBL] [Abstract][Full Text] [Related]
34. Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
De Monte C; Carradori S; Bizzarri B; Bolasco A; Caprara F; Mollica A; Rivanera D; Mari E; Zicari A; Akdemir A; Secci D
Eur J Med Chem; 2016 Jan; 107():82-96. PubMed ID: 26562544
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative and tumor inhibitory studies of 2,3 disubstituted 4-thiazolidinone derivatives.
Sharath Kumar KS; Hanumappa A; Vetrivel M; Hegde M; Girish YR; Byregowda TR; Rao S; Raghavan SC; Rangappa KS
Bioorg Med Chem Lett; 2015 Sep; 25(17):3616-20. PubMed ID: 26152430
[TBL] [Abstract][Full Text] [Related]
36. QSAR study of isatin analogues as in vitro anti-cancer agents.
Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
[TBL] [Abstract][Full Text] [Related]
37. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives.
Skóra B; Lewińska A; Kryshchyshyn-Dylevych A; Kaminskyy D; Lesyk R; Szychowski KA
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164157
[TBL] [Abstract][Full Text] [Related]
40. Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine 4-one derivatives as potent anti-tubercular agents.
Moulishankar A; Thirugnanasambandam S
J Recept Signal Transduct Res; 2023 Jun; 43(3):83-92. PubMed ID: 37990804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
